NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that Aetna has agreed to cover its ThyraMir microRNA classifier test for thyroid nodules.
NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that Aetna has agreed to cover its ThyraMir microRNA classifier test for thyroid nodules.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.